Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon
HeartFlow's RoadMap technology where AI reads the image in a first pass to highlight areas of interest with for the radiologist or cardiologist on coronary CT scan. The technology was shown to reduce reading time by 25%.

Three studies show value of AI to speed cardiac CT reads and soft plaque evaluation 

AI to help interpret cardiac CT was shown to reduce exam read times to improve workflow efficiency, and improve patient diagnostics with additional information on soft plaques. Data was presented in three HeartFlow AI technology studies at SCCT 2023.

FDA clears new AI to guide point-of-care cardiac ultrasound exams

The FDA approved UltraSight's AI to show ultrasound users how to perform a diagnostic quality cardiac ultrasound exam at the point of care in multiple settings.

Video of Maddie Jankowski explaining sonographer highlights and trends at the American Society of Echo (ASE) 2023 meeting.

The rise of AI and other key takeaways for sonographers at ASE 2023

Cardiac sonographer Maddie Jankowski, BS, ACS, RDCS, joined us to explore key trends and updates for sonographers from ASE 2023 in National Harbor, Maryland. 

Axial planes suggested for screening the fetal heart at the time of the obstetric anatomic survey and as an initial series obtained during fetal echocardiography. #Fetalecho

ASE updates fetal echocardiography guidelines

The new 44-page document focuses on the detection, classification and risk assessment of congenital heart issues.

Artificial intelligence (AI) model using chest x-rays to evaluate cardiac function

No echocardiography, no problem? AI evaluates cardiac function using chest X-rays

Researchers think their new AI model could be especially helpful in areas where qualified physicians and/or ultrasound technology are in short supply.

Roosha Parikh, MD, advanced imaging cardiologist, St. Francis Heart Hospital, Long Island, New York, and a clinical assistant professor of medicine at the State University of New York at Stony Brook, presented in one of the ASE 2023 amyloid sessions and spoke with Cardiovascular Business about the disease.

Amyloidosis now a hot topic in cardiac imaging due to new drug treatment

Advanced cardiac imager Roosha Parikh, MD, explained that cardiac amyloidosis is regularly misdiagnosed. It can often be identified in echocardiography results, however, if physicians know how to identify it. 

Stephen Little, MD, discusses trends in echocardiography at ASE 2023. #ASE23 #ASE2023 What is new in cardiac ultrasound.

Back in the spotlight: Exploring echocardiography's revival

American Society of Echocardiography President Stephen Little, MD, says several trends and technologies are coming together at once, leading to renewed interest in echo.

dipyridamole injection drug shortage heart imaging Canada

‘I have no dose for anyone right now’: Drug shortage hits cardiologists in Canada, leading to delays

“It's very important,” one cardiologist said. “This is a life-saving test and it's very frustrating that we can't access the medication.”

Displaying 137 - 144 of 1766

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup